Related Experiment Video
Updated: Sep 3, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Sample size calculation for active-arm trial with counterfactual incidence based on recency assay
Fei Gao1, David V Glidden2, James P Hughes3
1Fred Hutchinson Cancer Research Center, Seattle, USA.
New methods can estimate HIV incidence in trials for pre-exposure prophylaxis (PrEP) without a placebo group. This approach uses HIV recency assays, enabling efficient trials for new HIV prevention strategies.
Area of Science:
- Biomedical science
- Epidemiology
- Public health
Background:
- Significant advancements in pre-exposure prophylaxis (PrEP) for HIV prevention have been made.
- New PrEP medications and delivery methods are under development to expand options.
- Future non-inferiority trials face feasibility challenges due to high efficacy of current PrEP.
Purpose of the Study:
- To develop a feasible method for evaluating new PrEP efficacy.
- To construct a counterfactual estimate of HIV incidence for control groups.
- To enable efficient clinical trials for novel HIV prevention strategies.
Main Methods:
- Proposing a cohort study augmenting HIV screening with laboratory markers for recent infections.
- Developing assumptions for estimating counterfactual HIV incidence.
- Conducting sample size and power calculations for trial comparisons.
Main Results:
- The proposed method allows for reasonable sample sizes and desirable statistical power in simulations.
- Hypothetical trials for men who have sex with men (MSM), transgender women (TGW), and young women in sub-Saharan Africa were considered.
- Calculated sample sizes were found to be feasible.
Conclusions:
- One-arm trials utilizing counterfactual placebo incidence derived from recency assays are feasible.
- These trials can be conducted with reasonable screening sample sizes.
- Adequate statistical power can be achieved to determine treatment efficacy for new PrEP agents.
More Related Videos
Related Concept Videos
Sample Size Calculation
The sample size for the given experiment or sampling effort is fundamental to any study design. Sample size decides the number of...
Actuarial Approach
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Odds Ratio
Testing a Claim about Population Proportion
There are two methods of testing a claim about a population proportion: (1) Using the sample proportion from the data where a binomial distribution is approximated to the normal distribution and (2) Using the binomial probabilities calculated from the data.
The first method uses normal distribution as an approximation to the binomial distribution. The requirements are as follows: sample size is large...
Assumptions of Survival Analysis

